About Us
Services
Therapeutic Area Expertise
Devices
Data Management
Max Neeman Differentiators
Careers
Contact Us
Testimonials
Max Neeman SOPs
DATA MANAGEMENT
MONITORING DEPARTMENT
SITE MANAGEMENT
IT SECURITY
Quality Assurance
PHARMACY
ADMINISTRATIVE
REGULATORY
BUSINESS DEVELOPMENT
HR SOPs
FINANCE SOPs
MSW
Links
FAQs
Site Map
Max Neeman Mails
Training Presentation
Knowledge Management
Articles
Friday Training Presentations
Max Medical Journals
Contact For Feasibility
Discussion Forum
Neeman & Industry News
DCGI to implement e-Gov in its working
The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization
Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million
MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials
The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...
more...
Site Map
This sitemap has been provided to help you access any page on this website at just a click of the button. Happy browsing!
Home
About Us
The Parent Company Max
Max Neeman International
Vision & Mission
Milestones
Core Values
Management Team
Our Presence
Why India
Services
Monitoring Services
Site Feasibility And Site Selection
Monitoring
Regulatory Service
Medical Monitoring
Medical And Other Scientific Services
Data Management & Report Writing
Project Management
Central Ware House Services
Regulatory Service
Indian Regulatory
Site Management
Site Feasibility & Site Selection
Ethics Committee Submission & Approval
Regulatory Services
Drug Warehousing/ Drug Supply Management
Site Coordination
Clinical Auditing and Training
Clinical Audit Services
Training
Central Lab
Max Neeman Differentiators
Overview
Nutraceuticals
Biosimilars
Cosmetics
Testimonials
Max Neeman SOPs
DATA MANAGEMENT
MONITORING DEPARTMENT
SITE MANAGEMENT
IT SECURITY
MSW
Quality Assurance
PHARMACY
ADMINISTRATIVE
REGULATORY
BUSINESS DEVELOPMENT
HR SOPs
FINANCE SOPs
Therapeutic Area Expertise
Overview
Dermatology
Oncology
Chemotherapy Induced Nausea & Vomiting
Colorectal Carcinoma
Esophageal Cancer
Head and neck Cancer
Lung Carcinoma
Oral Cancer
Ovarian Cancer
Prostate Cancer
Cervical Cancer
Neurology and Neuro-Surgery
Alzheimer's Disease
Multiple Sclerosis
Parkinson's Disease
Endocrinology & Metabolic disorders
Diabetes
Cardiology
Acute Coronary Syndrome
Acute Myocardial Infarction
Angina pectoris
Atherosclerosis
Cardiac Arrhythmia
Hypertension
HIV/AIDS
Pulmonology
Bronchial Asthma
Chronic Obstructive Pulmonary Disease
Psychiatry
Gastroenterology
Ophthalmology
Data Management
Data Management Services
Careers
Culture Of Max Neeman
Testimonials
Submit Your Resume
Current Openings
Contact Us
Links
FAQs
Site Map
Max Neeman Mails
Disclaimer
Privacy Policy
Upcoming Conferences
Training Presentation
Knowledge Management
Articles
Friday Training Presentations
Devices
Device Studies
Case Studies
Device Trial Regulation
Contact For Feasibility
Discussion Forum
Neeman News
Industry News
www.maxindia.com
Testimonials
|
Max Neeman SOPs
|
Links
|
FAQs
|
Site Map
|
Max Neeman Mails
|
Training Presentation
|
Knowledge Management
|
Contact For Feasibility
|
Discussion Forum
© Copyright 2008 Max Neeman. All Rights Reserved.
Disclaimer
|
Privacy Policy
Powered By: